NCT04349397

Brief Summary

The purpose of the study is to quantify the use of pain medications given to children aged 3 - 12 years as well as their pain level through pain scores after they have undergone a tonsillectomy or adenotonsillectomy surgery at Doernbecher Children's Hospital (DCH). We would like to learn more about the pain medications given and the pain scores of children post-surgery for the first 5 days following discharge from the hospital.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 16, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

April 16, 2020

Status Verified

April 1, 2020

Enrollment Period

1.3 years

First QC Date

April 14, 2020

Last Update Submit

April 14, 2020

Conditions

Keywords

tonsillectomyadenotonsillectomy

Outcome Measures

Primary Outcomes (1)

  • Total opioid administered during POD 1-5 (converted to morphine dose equivalents)

    Total amount of opioid analgesics administered at home on Post-operative days 1-5.

    POD 1-5

Secondary Outcomes (7)

  • Mean Worst Pain Scores POD 1-5

    POD 1-5

  • Total acetaminophen administered on POD 1-5

    POD 1-5

  • Total ibuprofen administered on POD 1-5

    POD 1-5

  • Frequency of Vomiting on POD 1-5

    POD 1-5

  • Duration of impaired drinking

    POD 1-5

  • +2 more secondary outcomes

Study Arms (1)

Pediatric tonsillectomy patients

All patients enrolled into study prior to undergoing tonsillectomy or adenotonsillectomy

Behavioral: Medication Tracking Form

Interventions

Parents will complete medication tracking form for 5 days after child's surgery. They will track medications administered, pain scores, nausea and vomiting

Pediatric tonsillectomy patients

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

1. Parent or guardian refusal of consent 2. Child has severe OSA (Apnea-Hypopnea Index (AHI) ≥10 or O2 Saturation \<85% on polysomnogram) 3. Child with behavioral disorders (ADHD, ASD, etc.) 4. Child with genetic disorders (down syndrome, mucopolysaccharidoses, achondroplasia, Prader-Willi syndrome, etc.) 5. Child with neuromuscular disorders (muscular dystrophy, hypotonia, etc.) 6. Child with a history of extremely preterm (born at \<28 weeks) or very preterm (born at 28-32 weeks) 7. Child with moderate to severe developmental delay 8. Child is obese (BMI ≥ 95th percentile) 9. Child with craniofacial anomalies (retrognathia, micrognathia, midface hypoplasia) 10. Child with allergies to acetaminophen, ibuprofen, morphine, fentanyl or oxycodone

You may qualify if:

  • Child aged 3-12 that is scheduled to undergo tonsillectomy or adenotonsillectomy, with or without ear tubes or Parent or guardian of a child aged 3-12 years old that is scheduled to undergo tonsillectomy or adenotonsillectomy, with or without ear tubes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health & Science University (OHSU)

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 14, 2020

First Posted

April 16, 2020

Study Start

August 1, 2019

Primary Completion

December 1, 2020

Study Completion

June 1, 2021

Last Updated

April 16, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations